The Justice Department and several state attorneys general have filed a lawsuit to block UnitedHealth Group’s acquisition of Amedisys for $3.3 billion through Optum. The deal, which aimed to grow UHG’s presence in the home health and hospice industry, was scrutinized by the DOJ for antitrust concerns. The lawsuit alleges that the merger would eliminate competition between the two companies, affecting patients and healthcare professionals. Despite the divestiture of certain home health centers, the DOJ believes it is not enough to address the competitive issues. The outcome of the lawsuit is uncertain, with experts discussing potential implications under changing administrations.
Source link
Why the DOJ’s Lawsuit Against the UGH-Amedisys Merger May Not Go Anywhere
